本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Therapix Biosciences Ltd.

0.3170
0.0000
成交量:- -
成交額:- -
市值:181.31萬
市盈率:-0.11
高:0.3170
開:0.3170
低:0.3170
收:0.3170
52周最高:4.69
52周最低:0.2522
股本:571.97萬
流通股本:557.84萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.7977
每股收益(LYR):-170.1534
淨資產收益率:-9843.96%
總資產收益率:-89.87%
市淨率:129.51
市盈率(LYR):0.00

資料載入中...

2021/04/28

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/04/21

招股説明書

F-1 - Registration statement for certain foreign private issuers
2021/03/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/03

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/16

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/12

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/05

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/11/04

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/10/21

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/10/21

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/10/09

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/09/22

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/09/08

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/08/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]